Instadose Pharma Corp. (INSD)
OTCMKTS · Delayed Price · Currency is USD
0.2500
+0.2489 (22,627.27%)
Jul 31, 2025, 8:00 PM EDT
Instadose Pharma Company Description
Instadose Pharma Corp. engages in growing, cultivation, processing, and global distribution of medical-grade cannabinoid oil. The company was founded in 2017 and is based in Burlington, Canada.
Instadose Pharma Corp.
| Country | United States |
| Founded | 2017 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Antonio Franchino |
Contact Details
Address: 5500 North Service Road Burlington, Nevada L7L 6W6 Canada | |
| Phone | 905 218 3593 |
| Website | instadosepharma.com |
Stock Details
| Ticker Symbol | INSD |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | December - November |
| Reporting Currency | CAD |
| ISIN Number | US45783B1035 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Antonio Rocco Franchino | Chief Executive Officer and Chairman |
| Grant F. Sanders | Founder and Executive Officer |
| Lawrence M. Acton | Chief Operating Officer |
| Loren S. Greenspoon J.D., L.L.B. | Chief Legal Officer |